{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,1,30]],"date-time":"2024-01-30T15:37:31Z","timestamp":1706629051075},"reference-count":102,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[1997,5,1]],"date-time":"1997-05-01T00:00:00Z","timestamp":862444800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Med. Klin."],"published-print":{"date-parts":[[1997,5]]},"DOI":"10.1007\/bf03045081","type":"journal-article","created":{"date-parts":[[2009,6,11]],"date-time":"2009-06-11T03:46:00Z","timestamp":1244691960000},"page":"265-272","source":"Crossref","is-referenced-by-count":2,"title":["Interferontherapie und Autoimmunit\u00e4t","Interferon therapy and autoimmunity"],"prefix":"10.1007","volume":"92","author":[{"given":"J\u00f6rg","family":"Fritzsch","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J\u00fcrgen","family":"Krug","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hans-J\u00fcrgen","family":"Heberling","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"BF03045081_CR1","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1111\/j.1600-0609.1986.tb02290.x","volume":"36","author":"E. A. Abdi","year":"1986","unstructured":"Abdi, E. A., W. Brien, P. M. Vermer: Auto-immune thrombocytopenia related to interferon therapy. Scand. J. Haemat. 36 (1986), 515\u2013519.","journal-title":"Scand. J. Haemat."},{"key":"BF03045081_CR2","doi-asserted-by":"crossref","first-page":"306","DOI":"10.7326\/0003-4819-105-2-306_1","volume":"105","author":"L. P. Akard","year":"1986","unstructured":"Akard, L. P., R. Hoffmann, L. Elias, J. H. Saiers: Alpha-interferon and immune hemolytic anemia. Ann. intern. Med. 105 (1986), 306.","journal-title":"Ann. intern. Med."},{"key":"BF03045081_CR3","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/BF02171758","volume":"4","author":"S. Ariad","year":"1992","unstructured":"Ariad, S., E. Song, R. Cohen, W. R. Bezwoda: Interferon-alpha induced autoimmune hepatitis in a patient with Philadelphia chromosome-positive chronic myeloid leukemia with cytogenetically normal T lymphocytes. Mol. Biother. 4 (1992), 139\u2013142.","journal-title":"Mol. Biother."},{"key":"BF03045081_CR4","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1056\/NEJM198806163182401","volume":"318","author":"M. B. Atkins","year":"1988","unstructured":"Atkins, M. B., J. W. Mier, D. R. Parkinson, J. A. Gould, E. M. Berkman, M. M. Kaplan: Hypothyroidism after treatment with interleukin-2 and lymphokine-activated killer cells. New Engl. J. Med. 318 (1988), 1557\u20131563.","journal-title":"New Engl. J. Med."},{"issue":"Suppl. 13","key":"BF03045081_CR5","first-page":"63","volume":"14","author":"A. D. Bankhurst","year":"1987","unstructured":"Bankhurst, A. D.: Interferons and systemic lupus erythematosus. J. Rheum. 14, Suppl. 13 (1987), 63\u201367.","journal-title":"J. Rheum."},{"key":"BF03045081_CR6","first-page":"58","volume":"7","author":"T. Barreca","year":"1993","unstructured":"Barreca, T., A. Picciotto, R. Franceschini, G. Varagona, G. Corsini, F. Valle, A. Cataldi, E. Molinari, A. Garibaldi, E. Rolandi: Long term therapy with recombinant interferon alpha 2b in patients with chronic hepatitis C: Effects on thyroid function and autoantibodies. J. biol. Regul. homeost. Agents 7 (1993), 58\u201362.","journal-title":"Agents"},{"key":"BF03045081_CR7","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1111\/j.1365-2265.1993.tb02423.x","volume":"39","author":"E. Baudin","year":"1993","unstructured":"Baudin, E., P. Marcellin, M. Pouteau, N. Colas-Linhart, J.-P. Le Floch, C. Lemmonier, J.-P. Benhamou, B. Bok: Reversibility of thyroid dysfunction induced by recombinant alpha interferon in chronic hepatitis C. Clin. Endocr. 39 (1993), 657\u2013661.","journal-title":"Clin. Endocr."},{"key":"BF03045081_CR8","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1002\/1097-0142(19940315)73:6<1621::AID-CNCR2820730613>3.0.CO;2-E","volume":"73","author":"J. C. Becker","year":"1994","unstructured":"Becker, J. C., B. Winkler, S. Klingert, E.-B. Br\u00f6cker: Antiphospholipid syndrome associated with immunotherapy for patients with melanoma. Cancer 73 (1994), 1621\u20131624.","journal-title":"Cancer"},{"issue":"Suppl. 2","key":"BF03045081_CR9","first-page":"121","volume":"15","author":"P. Beck-Peccoz","year":"1992","unstructured":"Beck-Peccoz, P., D. Preziati, R. Marcelli, L. Persani, M. G. Rumi, E. Del Ninno, G. Faglia: High incidence of thyroid autoimmunity in patients with chronic hepatitis C: Effects of treatment with recombinant human interferon \u03b1-2a (rhIFN\u03b1). J. endocr. Invest 15, Suppl. 2 (1992), 121.","journal-title":"J. endocr. Invest"},{"key":"BF03045081_CR10","doi-asserted-by":"crossref","first-page":"470","DOI":"10.7326\/0003-4819-99-4-470","volume":"99","author":"J. D. Bellone","year":"1983","unstructured":"Bellone, J. D., T. J. Kunicki, R. H. Aster: Immune thrombocytopenia associated with carcinoma. Ann. intern. Med. 99 (1983), 470\u2013472.","journal-title":"Ann. intern. Med."},{"key":"BF03045081_CR11","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1007\/BF01296413","volume":"36","author":"B. Berris","year":"1991","unstructured":"Berris, B., S. V. Feinman: Thyroid dysfunction and liver injury following alpha-interferon treatment of chronic viral hepatitis. Dig. Dis. Sci. 36 (1991), 1657\u20131660.","journal-title":"Dig. Dis. Sci."},{"key":"BF03045081_CR12","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/S0140-6736(85)92785-0","volume":"2","author":"H. Bhakri","year":"1985","unstructured":"Bhakri, H., K. Sriskandan, T. Davis, K. Pettingale, D. Tee: Recombinant gamma interferon and autoimmune thyroid disease. Lancet 2 (1985), 457.","journal-title":"Lancet"},{"key":"BF03045081_CR13","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1016\/S0140-6736(83)90629-3","volume":"2","author":"G. F. Bottazzo","year":"1983","unstructured":"Bottazzo, G. F., R. Pujol-Borrell, T. Hanafusa, M. Feldmann: Role of aberrant HLA-DR expression and antigen presentation in induction of endocrine autoimmunity. Lancet 2 (1983), 1115\u20131118.","journal-title":"Lancet"},{"key":"BF03045081_CR14","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1136\/bmj.298.6689.1713-b","volume":"298","author":"L. R. Braathen","year":"1989","unstructured":"Braathen, L. R., P. Stavem: Autoimmune haemolytic anaemia associated with interferon alfa-2a in patient with mycosis fungoides. Brit. med. J. 298 (1989), 1713.","journal-title":"Brit. med. J."},{"key":"BF03045081_CR15","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1210\/jcem-63-5-1086","volume":"63","author":"P. Burman","year":"1986","unstructured":"Burman, P., T. H. T\u00f6tterman, K. \u00d6berg, F. A. Karlsson: Thyroid autoimmunity in patients on long term therapy with leucocyte-derived interferon. J. clin. Endocr. Metab. 63 (1986), 1086\u20131090.","journal-title":"J. clin. Endocr. Metab."},{"key":"BF03045081_CR16","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1111\/j.1440-1746.1992.tb01013.x","volume":"7","author":"G. C. B. Chan","year":"1992","unstructured":"Chan, G. C. B., S. S. Lee, E. K. Yeoh: Mono-arthritis in a chronic hepatitis B patient after \u03b1-interferon treatment. J. Gastroent. Hepatol. 7 (1992), 432\u2013433.","journal-title":"J. Gastroent. Hepatol."},{"key":"BF03045081_CR17","first-page":"303","volume":"59","author":"P. Chazerain","year":"1992","unstructured":"Chazerain, P., O. Meyer, P. Ribard, M. De Brandt, C. Mechelany, P. Marcellin, J. F. Bernard, M. Grossin, M. F. Kahn: Trois cas de polyarthrite survenant au cours d\u2019un traitement par interf\u00e9ron-alpha recombinant. Rev. Rhum. Mal. Ost\u00e9oartic. 59 (1992), 303\u2013309.","journal-title":"Rev. Rhum. Mal. Ost\u00e9oartic."},{"key":"BF03045081_CR18","first-page":"244","volume":"88","author":"Y.-H. Chung","year":"1993","unstructured":"Chung, Y.-H., Y. K. Shong: Development of thyroid autoimmunity after administration of recombinant human interferon-\u03b12b for chronic viral hepatitis. Amer. J. Gastroent. 88 (1993), 244\u2013247.","journal-title":"Amer. J. Gastroent."},{"key":"BF03045081_CR19","doi-asserted-by":"crossref","first-page":"2237","DOI":"10.1002\/1097-0142(19900515)65:10<2237::AID-CNCR2820651013>3.0.CO;2-5","volume":"65","author":"K. C. Conlon","year":"1990","unstructured":"Conlon, K. C., W. J. Urba, J. W. Smith, R. G. Steis, D. L. Longo, J. W. Clark: Exacerbation of symptoms of autoimmune disease in patients receiving alpha-interferon therapy. Cancer 65 (1990), 2237\u20132242.","journal-title":"Cancer"},{"key":"BF03045081_CR20","first-page":"287","volume":"78","author":"J. Demeter","year":"1993","unstructured":"Demeter, J., K. P\u00e1l\u00f3czi, D. Lehoczky, M. H\u00f8ier-Madsen, A. Wiik: Autoantibody occurrence in hairy cell leukemia. Haematologica 78 (1993), 287\u2013290.","journal-title":"Haematologica"},{"key":"BF03045081_CR21","first-page":"225","volume":"16","author":"M. Derwahl","year":"1993","unstructured":"Derwahl, M.: Cytokine und Autoimmunthyreoiditis. Nuklearmediziner 16 (1993), 225\u2013230.","journal-title":"Nuklearmediziner"},{"key":"BF03045081_CR22","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1007\/BF02231591","volume":"12","author":"L. D\u2019Hondt","year":"1993","unstructured":"D\u2019Hondt, L., A. Delannoy, C. Docquier: Hypothyroidism and arthritis during interferon therapy. Clin. Rheum. 12 (1993), 415\u2013417.","journal-title":"Clin. Rheum."},{"key":"BF03045081_CR23","first-page":"317","volume":"112","author":"J. Eisenburg","year":"1994","unstructured":"Eisenburg, J.: Interferon- oder Virus-C-induzierte autoimmune chronische Hepatitis? Fortschr. Med. 112 (1994), 317\u2013321.","journal-title":"Fortschr. Med."},{"key":"BF03045081_CR24","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/0140-6736(92)91744-S","volume":"340","author":"P. Fabris","year":"1992","unstructured":"Fabris, P., C. Betterle, A. Floreani, N. A. Greggio, F. De Lazzari, R. Naccarato, M. Chiaramonte: Development of type 1 diabetes mellitus during interferon alfa therapy for chronic HCV hepatitis. Lancet 340 (1992), 548.","journal-title":"Lancet"},{"key":"BF03045081_CR25","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1002\/jmv.1890340212","volume":"34","author":"G. Fattovich","year":"1991","unstructured":"Fattovich, G., C. Betterle, L. Brollo, B. Pedini, G. Giustina, G. Realdi, A. Alberti, A. Ruol: Autoantibodies during \u03b1-interferon therapy for chronic hepatitis B. J. med. Virol. 34 (1991), 132\u2013135.","journal-title":"J. med. Virol."},{"key":"BF03045081_CR26","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1016\/0277-5379(88)90219-2","volume":"24","author":"I. S. Fentiman","year":"1988","unstructured":"Fentiman, I. S., F. R. Balkwill, B. S. Thomas, M. J. Russell, I. Todd, G. F. Bottazzo: An autoimmune aetiology for hypothyroidism following interferon therapy for breast cancer. Europ. J. Cancer clin. Oncol. 24 (1988), 1299\u20131303.","journal-title":"Europ. J. Cancer clin. Oncol."},{"key":"BF03045081_CR27","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1530\/acta.0.1250491","volume":"125","author":"V. Fonseca","year":"1991","unstructured":"Fonseca, V., M. Thomas, G. Dusheiko: Thyrotropin receptor antibodies following treatment with recombinant \u03b1-interferon in patients with hepatitis. Acta endocr. (Kbh.) 125 (1991), 491\u2013493.","journal-title":"Acta endocr. (Kbh.)"},{"key":"BF03045081_CR28","first-page":"596","volume":"13","author":"G. Fornaciari","year":"1991","unstructured":"Fornaciari, G., C. Bassi, M. Beltrami, E. Castagnetti, S. Maccari, A. C. Plancher: Hemolytic anemia secondary to interferon treatment for chronic B hepatitis. J. clin. Gastroent. 13 (1991), 596\u2013597.","journal-title":"J. clin. Gastroent."},{"key":"BF03045081_CR29","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1111\/j.1365-2133.1991.tb14774.x","volume":"125","author":"J. Funk","year":"1991","unstructured":"Funk, J., T. Langeland, E. Schrumpf, L. E. Hanssen: Psoriasis induced by interferon-\u03b1. Brit. J. Derm. 125 (1991). 463\u2013465.","journal-title":"Brit. J. Derm."},{"key":"BF03045081_CR30","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1159\/000204881","volume":"85","author":"F. J. Giles","year":"1991","unstructured":"Giles, F. J., C. P. Worman, A. P. Jewell, A. H. Goldstone: Recombinant alpha-interferons, thyroid irradiation and thyroid disease. Acta haemat. 85 (1991), 160\u2013163.","journal-title":"Acta haemat."},{"key":"BF03045081_CR31","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1111\/j.1365-2249.1992.tb05852.x","volume":"90","author":"H. Gisslinger","year":"1992","unstructured":"Gisslinger, H., B. Gilly, W. Woloscuk, W. R. Mayr, L. Havelec, W. Linkesch, M. Weissel: Thyroid autoimmunity and hypothyroidism during long-term treatment with recombinant interferon-alpha. Clin. exp. Immunol. 90 (1992), 363\u2013367.","journal-title":"Clin. exp. Immunol."},{"key":"BF03045081_CR32","first-page":"1621","volume":"18","author":"W. B. Graninger","year":"1991","unstructured":"Graninger, W. B., W. Hassfeld, B. B. Pesau, K. P. Machold, C. C. Zielinski, J. S. Smolen: Induction of systemic lupus erythematosus by interferon-\u03b3 in a patient with rheumatoid arthritis. J. Rheum. 18 (1991), 1621\u20131622.","journal-title":"J. Rheum."},{"key":"BF03045081_CR33","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1073\/pnas.91.4.1198","volume":"91","author":"J. U. Gutterman","year":"1994","unstructured":"Gutterman, J. U.: Review \u2014 Cytokine therapeutics: lessons from interferon a. Proc. nat. Acad. Sci. (Wash.) 91 (1994), 1198\u20131205.","journal-title":"Proc. nat. Acad. Sci. (Wash.)"},{"key":"BF03045081_CR34","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/S0140-6736(86)92161-6","volume":"2","author":"P. V. Harrison","year":"1986","unstructured":"Harrison, P. V., M. J. Peat: Effect of interferon on psoriasis. Lancet 2 (1986), 457\u2013458.","journal-title":"Lancet"},{"key":"BF03045081_CR35","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1055\/s-2008-1066559","volume":"114","author":"F. Hartmann","year":"1989","unstructured":"Hartmann, F., P. von Wussow, H. Deicher: Psoriasis-Exazerbation bei Therapie mit \u03b1-Interferon. Dtsch. med. Wschr. 114 (1989), 96\u201398.","journal-title":"Dtsch. med. Wschr."},{"key":"BF03045081_CR36","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1097\/00002371-199112000-00009","volume":"10","author":"E. L. Jacobs","year":"1991","unstructured":"Jacobs, E. L., M. Clare-Salzler, I. J. Chopra, R. A. Figlin: Thyroid function abnormalitics associated with the chronic outpatient administration of recombinant interleukin-2 and recombinant interferon-alpha. J. Immunother. 10 (1991), 448\u2013455.","journal-title":"J. Immunother."},{"key":"BF03045081_CR37","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1001\/archderm.1991.01680050156027","volume":"127","author":"A. Jucgla","year":"1991","unstructured":"Jucgla, A., J. Marcoval, N. Curco, O. Servitje: Psoriasis with articular involvement induced by interferon alfa. Arch. Derm. 127 (1991), 909\u2013910.","journal-title":"Arch. Derm."},{"key":"BF03045081_CR38","first-page":"1175","volume":"35","author":"U. Kaboth","year":"1994","unstructured":"Kaboth, U., W. Hiddemann: Paraneoplastische Syndrome. Internist (Berl.) 35 (1994), 1175\u20131180.","journal-title":"Internist (Berl.)"},{"key":"BF03045081_CR39","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1111\/j.1600-0609.1990.tb00462.x","volume":"45","author":"M. K\u00e4lkner","year":"1990","unstructured":"K\u00e4lkner, M., H. Hagberg, A. Karlsson-Parra: Autoantibody occurrence in hairy-cell leukemia during prolonged interferon treatment. Europ. J. Haematol. 45 (1990), 233\u2013234.","journal-title":"Europ. J. Haematol."},{"key":"BF03045081_CR40","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1136\/bmj.297.6663.1613-b","volume":"297","author":"J. Kanfer","year":"1988","unstructured":"Kanfer, J., D. M. McCarthy: Immune thrombocytopenia and interferon alfa. Brit. med. J. 297 (1988), 1613.","journal-title":"Brit. med. J."},{"key":"BF03045081_CR41","first-page":"293","volume-title":"Autoimmune thyroiditis. Approaches towards its etiological differentiation","author":"F. A. Karlsson","year":"1991","unstructured":"Karlsson, F. A., P. Burman, K. \u00d6berg, A. Karlsson-Parra: Thyroid autoimmunity induced by interferon therapy. In: Scherbaum, W. A., U. Bogner, B. Weinheimer, G. F. Bottazzo: Autoimmune thyroiditis. Approaches towards its etiological differentiation. Springer, Berlin \u2014 Heidelberg \u2014 New York 1991, p. 293\u2013296."},{"key":"BF03045081_CR42","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1111\/j.1365-2249.1990.tb05293.x","volume":"81","author":"A. Karlsson-Parra","year":"1990","unstructured":"Karlsson-Parra, A., P. Burman, H. Hagberg, K. \u00d6berg, G. Alms, L. Klareskog, F. A. Karlsson: Autoantibodies to epithelial cells in patients on long-term therapy with leucocyte-derived interferon-\u03b1 (IFN-\u03b1). Clin. exp. Immunol. 81 (1990), 72\u201375.","journal-title":"Clin. exp. Immunol."},{"key":"BF03045081_CR43","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1530\/acta.0.1220041","volume":"122","author":"Y. Kawamaki","year":"1990","unstructured":"Kawamaki, Y., N. Kuzuya, T. Watanabe, Y. Uchiyama, K. Yamashita: Induction of experimental thyroiditis in mice by recombinant interferon \u03b3 administration. Acta endocr. (Kbh.) 122 (1990), 41\u201348.","journal-title":"Acta endocr. (Kbh.)"},{"key":"BF03045081_CR44","doi-asserted-by":"crossref","first-page":"3684","DOI":"10.4049\/jimmunol.138.11.3684","volume":"138","author":"J. Knop","year":"1987","unstructured":"Knop, J., B. Taborski, J. de Maeyer-Guignard: Selective inhibition of the generation of T suppressor cells of contact sensitivity in vitro by interferon. J. Immunol. 138 (1987), 3684\u20133687.","journal-title":"J. Immunol."},{"key":"BF03045081_CR45","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1007\/BF02358367","volume":"29","author":"T. Kodama","year":"1994","unstructured":"Kodama, T., S. Katabami, K. Kamijo, A. Katanuma, K. Yamashita, N. Azuma, T. Tamaki, A. Yachi: Development of transient thyroid disease and reaction during treatment of chronic hepatitis C with interferon. J. Gastroent. 29 (1994), 289\u2013292.","journal-title":"J. Gastroent."},{"key":"BF03045081_CR46","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1159\/000236840","volume":"106","author":"J. Krug","year":"1995","unstructured":"Krug, J., J. Fritzsch, G. Aust: Induction of insulin antibodies and insulin allergy under alpha-interferon treatment of renal cell carcinoma in a patient with insulin-treated diabetes mellitus \u2014 a case report. Int. Arch. Allergy Immunol. 106 (1995), 169\u2013172.","journal-title":"Int. Arch. Allergy Immunol."},{"key":"BF03045081_CR47","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1210\/jcem-71-5-1230","volume":"71","author":"A. W. C. Kung","year":"1990","unstructured":"Kung, A. W. C., B. M. Jones, C. L. Lai: Effects of interferon-\u03b3 therapy on thyroid function, T-lymphocyte subpopulations and induction of autoantibodies. J. clin. Endocr. Metab. 71 (1990), 1230\u20131234.","journal-title":"J. clin. Endocr. Metab."},{"key":"BF03045081_CR48","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1159\/000247916","volume":"181","author":"R. Ku\u0161ec","year":"1990","unstructured":"Ku\u0161ec, R., S. Ostoijic, A. Planinc-Peraica, H. Minigo, B. Jaksic: Exacerbation of psoriasis after treatment with alpha-interferon. Dermatologica 181 (1990), 170.","journal-title":"Dermatologica"},{"key":"BF03045081_CR49","doi-asserted-by":"crossref","first-page":"2065","DOI":"10.1001\/jama.1989.03420140067021","volume":"261","author":"D. Larrey","year":"1989","unstructured":"Larrey, D., P. Marcellin, E. Frenaux, D. Pessayre, J.-P. Benhamou. Exacerbation of multiple sclerosis after the administration of recombinant human interferon alfa. J. Amer. med. Ass. 261 (1989), 2065.","journal-title":"J. Amer. med. Ass."},{"key":"BF03045081_CR50","doi-asserted-by":"crossref","first-page":"2155","DOI":"10.1016\/0016-5085(92)90348-3","volume":"102","author":"M. Lisker-Melman","year":"1992","unstructured":"Lisker-Melman, M., A. M. Di Bisceglie, S. J. Usala, B. Weintraub, L. M. Murray, J. H. Hoofnagle: Development of thyroid disease during therapy of chronic viral hepatitis with interferon alfa. Gastroenterology 102 (1992), 2155\u20132160.","journal-title":"Gastroenterology"},{"key":"BF03045081_CR51","first-page":"809","volume":"87","author":"A. J. L\u00f3pez Morante","year":"1992","unstructured":"L\u00f3pez Morante, A. J., F. Sa\u00e9z-Royuela, F. Casanova Valero, L. Yuguero del Moral, J. L. Mart\u00edn Lorente, C. Ojeda Gim\u00e9nz: Immune thrombocytopenia after \u03b1-interferon therapy in a patient with chronic hepatitis C. Amer. J. Gastroent. 87 (1992), 809\u2013810.","journal-title":"Amer. J. Gastroent."},{"key":"BF03045081_CR52","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1007\/BF02206672","volume":"10","author":"S. Maccari","year":"1991","unstructured":"Maccari, S., C. Bassi, A. G. Giovannini, A. C. Plancher: A case of arthropathy and hypothyroidism during recombinant alpha-interferon therapy. Clin. Rheum. 10 (1991), 452\u2013454.","journal-title":"Clin. Rheum."},{"key":"BF03045081_CR53","first-page":"1096","volume":"34","author":"M. P. Manns","year":"1993","unstructured":"Manns, M. P., K. H. W. B\u00f6ker: Was ist gesichert in der Therapie der chronischen Virushepatitis? Internist (Berl.) 34 (1993), 1096\u20131106.","journal-title":"Internist (Berl.)"},{"key":"BF03045081_CR54","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1016\/S0248-8663(05)80127-4","volume":"14","author":"O. Marcais","year":"1993","unstructured":"Marcais, O., B. Hanslik, F. Coste, P. Perney, J. Clot, F. Blanc: Anomalies biologiques autoimmunes chez 35 malades atteints d\u2019h\u00e9patite chronique virale C trait\u00e9s pendant six mois par interf\u00e9ron (IFN) et suivis pendant un an. Rev. Med. intern. 14 (1993), 1009.","journal-title":"Rev. Med. intern."},{"key":"BF03045081_CR55","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1136\/gut.33.6.855","volume":"33","author":"P. Marcellin","year":"1992","unstructured":"Marcellin, P., M. Poteau, P. Renard, J.-M. Grynblat, N. Colas Linhart, P. Bardet, B. Bok, J.-P. Benhamou: Sustained hypothyroidism induced by recombinant \u03b1 interferon in patients with chronic hepatitis C. Gut 33 (1992), 855\u2013856.","journal-title":"Gut"},{"key":"BF03045081_CR56","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/0140-6736(90)90701-6","volume":"335","author":"F. Matthey","year":"1990","unstructured":"Matthey, F., S. Ardeman, L. Jones, A. C. Newland: Bleeding in immune thrombocytopenic purpura after alpha-interferon. Lancet 335 (1990), 471\u2013472.","journal-title":"Lancet"},{"key":"BF03045081_CR57","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1002\/hep.1840100106","volume":"10","author":"W.-J. Mayet","year":"1989","unstructured":"Mayet, W.-J., G. Hess, G. Gerken, S. Rossol, R. Voth, M. Manns, K.-H. Meyer zum B\u00fcschenfelde: Treatment of chronic type B hepatitis with recombinant \u03b1-interferon induces autoantibodies not specific for autoimmune chronic hepatitis. Hepatology 10 (1989), 24\u201328.","journal-title":"Hepatology"},{"key":"BF03045081_CR58","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1001\/jama.1985.03360100103022","volume":"254","author":"P. McLaughlin","year":"1985","unstructured":"McLaughlin, P., M. Talpaz, J. R. Quesada, A. Saleem, B. Barlogie, J. U. Gutterman: Immune thrombocytopenia following \u03b1-interferon therapy in patients with cancer. J. Amer. med. Ass. 254 (1985), 1353\u20131354.","journal-title":"J. Amer. med. Ass."},{"key":"BF03045081_CR59","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1002\/ajh.2830410215","volume":"41","author":"N. D. Mehta","year":"1992","unstructured":"Mehta, N. D., A. L. Hooberman, E. E. Vokes, S. Neeley, S. Cotler. 35-Year-old patient with chronic myelogenous leukemia developing systemic lupus erythematosus after \u03b1-interferon therapy. Amer. J. Hematol. 41 (1992), 141.","journal-title":"Amer. J. Hematol."},{"key":"BF03045081_CR60","doi-asserted-by":"crossref","first-page":"761","DOI":"10.4049\/jimmunol.139.3.761","volume":"139","author":"K. Morikawa","year":"1987","unstructured":"Morikawa, K., H. Kubagawa, T. Suzuki, M. D. Cooper: Recombinant Interferon-\u03b1,-\u03b2 and-\u03b3 enhance the proliferative response of human B cells. J. Immunol. 139 (1987), 761\u2013766.","journal-title":"J. Immunol."},{"key":"BF03045081_CR61","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1056\/NEJM198911303212217","volume":"321","author":"J.-F. Nicolas","year":"1989","unstructured":"Nicolas, J.-F., J. Thivolet: Interferon alfa therapy in severe unresponsive subacute cutaneous lupus erythematosus. New Engl. J. Med. 321 (1989), 1550\u20131551.","journal-title":"New Engl. J. Med."},{"issue":"Suppl. 1","key":"BF03045081_CR62","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1159\/000246954","volume":"189","author":"H. Niizeki","year":"1994","unstructured":"Niizeki, H., N. Inamoto, K. Nakamura, K. Tsuchimoto, T. Hashimoto, T. Nishikawa: A case of pemphigus foliaceus after interferon alpha-2a therapy. Dermatology 189, Suppl. 1 (1994), 129\u2013130.","journal-title":"Dermatology"},{"key":"BF03045081_CR63","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1093\/jnci\/81.7.531","volume":"81","author":"K. \u00d6berg","year":"1989","unstructured":"\u00d6berg, K., G. Alm, A. Magnusson, G. Lundquist, E. Theodorsson, L. Wide, E. Wilander: Treatment of malignant carcinoid tumors with recombinant interferon alfa-2b: Development of neutralizing interferon antibodies and possible loss of antitumor activity. J. nat. Cancer Inst. 81 (1989), 531\u2013535.","journal-title":"J. nat. Cancer Inst."},{"key":"BF03045081_CR64","doi-asserted-by":"crossref","first-page":"1766","DOI":"10.1055\/s-2008-1069083","volume":"110","author":"H.-J. Obert","year":"1985","unstructured":"Obert, H.-J., P. H. Hofschneider: Interferon bei chronischer Polyarthritis, Dtsch. med. Wschr. 110 (1985), 1766\u20131769.","journal-title":"Dtsch. med. Wschr."},{"key":"BF03045081_CR65","first-page":"80","volume":"19","author":"P. G. O\u2019Connell","year":"1992","unstructured":"O\u2019Connell, P. G., L. H. Gerber, J. H. Digiovannova, G. L. Peck: Arthritis in patients with psoriasis treated with gamma-interferon. J. Rheum. 19 (1992), 80\u201382.","journal-title":"J. Rheum."},{"key":"BF03045081_CR66","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1055\/s-2007-1003651","volume":"23","author":"M. C. Pagliacci","year":"1991","unstructured":"Pagliacci, M. C., G. Pelicci, M. Schippa, A. M. Liberati, I. Nicoletti: Does interferon-\u03b2 induce thyroid autoimmune phenomena? Horm. Metab. Res. 23 (1991), 196\u2013197.","journal-title":"Horm. Metab. Res."},{"key":"BF03045081_CR67","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1212\/WNL.37.7.1097","volume":"37","author":"H. S. Panitch","year":"1987","unstructured":"Panitch, H. S., R. L. Hirsch, J. Schindler, K. P. Johnson: Treatment of multiple sclerosis with gamma interferon: Exacerbations associated with activation of the immune system. Neurology (Minneap.) 37 (1987), 1097\u20131102.","journal-title":"Neurology (Minneap.)"},{"key":"BF03045081_CR68","doi-asserted-by":"crossref","first-page":"51","DOI":"10.7326\/0003-4819-116-1-51","volume":"116","author":"T. Papo","year":"1992","unstructured":"Papo, T., P. Marcellin, J. Bernuau, F. Durand, T. Poynard, J.-P. Benhamou: Autoimmune chronic hepatitis exacerbated by alpha-interferon. Ann. intern. Med. 116 (1992), 51\u201353.","journal-title":"Ann. intern. Med."},{"key":"BF03045081_CR69","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1159\/000247329","volume":"186","author":"A. Parodi","year":"1993","unstructured":"Parodi, A., M. Semino, R. Gallo, A. Rebora: Bullous eruption with circulating pemphigus-like antibodies following interferon-alpha therapy. Dermatology 186 (1993), 155\u2013157.","journal-title":"Dermatology"},{"key":"BF03045081_CR70","first-page":"77a","volume":"14","author":"D. Pateron","year":"1991","unstructured":"Pateron, D., I. Augier, J. C. Duclos-Vall\u00e9e, H. Jouanolle, D. J. Hartmann, M. Beaugrand: High prevalence of abnormal thyroid tests in patients with chronic hepatitis C (CHC) before alpha interferon (IFN) therapy: Relation with IFN induced thyroid dysfunction. Hepatology 14 (1991), 77a.","journal-title":"Hepatology"},{"key":"BF03045081_CR71","doi-asserted-by":"crossref","first-page":"2512","DOI":"10.1002\/1097-0142(19910515)67:10<2512::AID-CNCR2820671021>3.0.CO;2-5","volume":"67","author":"R. Perez","year":"1991","unstructured":"Perez, R., K. Padavic, R. Krigel, L. Weiner: Antiery-throcyte autoantibody formation after therapy with interleukin-2 and gamma-interferon. Cancer 67 (1991), 2512\u20132517.","journal-title":"Cancer"},{"key":"BF03045081_CR72","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1055\/s-2008-1040516","volume":"9","author":"M. Peters","year":"1989","unstructured":"Peters, M.: Mechanisms of action of interferon. Semin. Liver Dis. 9 (1989), 5\u20139.","journal-title":"Semin. Liver Dis."},{"key":"BF03045081_CR73","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1016\/S0140-6736(86)91502-3","volume":"1","author":"J. R. Quesada","year":"1986","unstructured":"Quesada, J. R., J. U. Gutterman: Psoriasis and alpha-interferon. Lancet 1 (1986), 1466\u20131468.","journal-title":"Lancet"},{"key":"BF03045081_CR74","first-page":"256","volume":"9","author":"A. P. Rabinowitz","year":"1990","unstructured":"Rabinowitz, A. P., E. Hu, K. Watkins, A. Mazumder: Hemolytic anemia in a cancer patient treated with recombinant interferon-\u03b3. J. biol. Response Mod. 9 (1990). 256\u2013259.","journal-title":"J. biol. Response Mod."},{"key":"BF03045081_CR75","first-page":"83","volume":"5","author":"A. I. Radin","year":"1991","unstructured":"Radin, A. I., P. Buckley, T. P. Duffy: Interferon therapy for agnogenic myeloid metaplasia complicated by immune hemolytic anemia. Hematol. Path. 5 (1991), 83\u201388.","journal-title":"Hematol. Path."},{"key":"BF03045081_CR76","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1111\/j.1365-2796.1990.tb00144.x","volume":"227","author":"L. E. R\u00f6nnblom","year":"1990","unstructured":"R\u00f6nnblom, L. E., G. V. Alm, K. E. \u00d6berg: Possible induction of systemic lupus erythematosus by interferon-\u03b1 treatment in a patient with a malignant carcinoid tumor. J. intern. Med. 227 (1990), 207\u2013210.","journal-title":"J. intern. Med."},{"key":"BF03045081_CR77","doi-asserted-by":"crossref","first-page":"537","DOI":"10.3109\/02841869109092414","volume":"30","author":"L. E. R\u00f6nnblom","year":"1991","unstructured":"R\u00f6nnblom, L. E., G. V. Alm, K. \u00d6berg: Autoimmune phenomena in patients with malignant carcinoid tumors during interferon-\u03b1 treatment. Acta oncol. (Madr.) 30 (1991), 537\u2013540.","journal-title":"Acta oncol. (Madr.)"},{"key":"BF03045081_CR78","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/0168-8278(90)90218-G","volume":"11","author":"G. Saracco","year":"1990","unstructured":"Saracco, G., A. Touscoz, M. Durazzo, F. Rosina, E. Donegani, L. Chiandussi, V. Gallo, R. Petrino, A. G. De Micheli, A. Solinas, A. Deplano, A. Tocco, P. A. Cossu, C. Pintus, G. Verme, M. Rizzetto: Autoantibodies and response to \u03b1-interferon in patients with chronic viral hepatitis. J. Hepatol. 11 (1990), 339\u2013343.","journal-title":"J. Hepatol."},{"key":"BF03045081_CR79","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/0002-9343(92)90278-J","volume":"92","author":"N. P. Sauter","year":"1992","unstructured":"Sauter, N. P., M. B. Atkins, J. W. Mier: Transient thyrotoxicosis and persistent hypothyroidism due to acute autoimmune thyroiditis after interleukin-2 and interferon-\u03b1 therapy for metastatic carcinoma: A case report. Amer. J. Med. 92 (1992), 441\u2013444.","journal-title":"Amer. J. Med."},{"key":"BF03045081_CR80","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1006\/clin.1994.1027","volume":"70","author":"A. Schattner","year":"1994","unstructured":"Schattner, A.: Lymphokines in autoimmunity \u2014 a critical review. Clin. Immunol. Immunopath. 70 (1994), 177\u2013189.","journal-title":"Clin. Immunol. Immunopath."},{"key":"BF03045081_CR81","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1002\/1097-0142(19911001)68:7<1536::AID-CNCR2820680713>3.0.CO;2-B","volume":"68","author":"P. J. Schilling","year":"1991","unstructured":"Schilling, P. J., R. Kurzrock, H. Kantarjian, J. U. Gutterman, M. Talpaz: Development of systemic lupus erythematosus after interferon therapy for chronic myelogenous leukemia. Cancer 68 (1991), 1536\u20131537.","journal-title":"Cancer"},{"key":"BF03045081_CR82","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1016\/S0140-6736(89)90157-8","volume":"1","author":"M. Schultz","year":"1989","unstructured":"Schultz, M., R. M\u00fcller, A. von zur M\u00fchlen, G. Brabant: Induction of hyperthyroidism by interferon-\u03b2-2b. Lancet 1 (1989), 1452.","journal-title":"Lancet"},{"key":"BF03045081_CR83","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1136\/ard.47.8.642","volume":"47","author":"M. Seitz","year":"1988","unstructured":"Seitz, M., M. Franke, H. Kirchner: Induction of antinuclear antibodies in patients with rheumatoid arthritis receiving treatment with human recombinant interferon gamma. Ann. rheum. Dis. 47 (1988), 642\u2013644.","journal-title":"Ann. rheum. Dis."},{"key":"BF03045081_CR84","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1016\/0016-5085(92)90786-X","volume":"102","author":"M. Shindo","year":"1992","unstructured":"Shindo, M., A. M. Di Bisceglie, J. H. Hoofnagle: Acute exacerbation of liver disease during interferon alfa therapy for chronic hepatitis C. Gastroenterology 102 (1992), 1406\u20131408.","journal-title":"Gastroenterology"},{"key":"BF03045081_CR85","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1016\/0016-5085(91)90547-X","volume":"101","author":"M. O. Silva","year":"1991","unstructured":"Silva, M. O., K. R. Reddy, L. J. Jeffers, M. Hill, E. R. Schiff: Interferon-induced chronic active hepatitis? Gastroenterology 101 (1991), 840\u2013842.","journal-title":"Gastroenterology"},{"key":"BF03045081_CR86","first-page":"350","volume":"21","author":"R. B. Stricker","year":"1994","unstructured":"Stricker, R. B., B. Barlogie, D. B. Kiprov: Acquired factor VIII inhibitor associated with chronic interferon-\u03b1-therapy. J. Rheum. 21 (1994), 350\u2013352.","journal-title":"J. Rheum."},{"key":"BF03045081_CR87","doi-asserted-by":"crossref","first-page":"373","DOI":"10.2169\/internalmedicine.31.373","volume":"31","author":"Y. Taniguchi","year":"1992","unstructured":"Taniguchi, Y., T. Murakami, K. Nakanishi, M. Tamai, B. Matsuura, T. Masumoto, M. Onji, J. Tajiri, S. Noguchi, Y. Ohta: Two cases of hypothyroidism associated with alpha-interferon therapy. Intern. Med. 31 (1992), 373\u2013376.","journal-title":"Intern. Med."},{"key":"BF03045081_CR88","first-page":"239","volume-title":"Autoimmune thyroiditis. Approaches towards its etiological differentiation","author":"I. Todd","year":"1991","unstructured":"Todd, I., V. Guerin, G. F. Bottazzo: Blocking the induction of HLA class II expression by thyroid epithelial cells in vitro. In: Scherbaum, W. A., U. Bogner, B. Weinheimer, G. F. Bottazzo: Autoimmune thyroiditis. Approaches towards its etiological differentiation. Springer. Berlin-Heidelberg-New York 1991, p. 239\u2013246."},{"key":"BF03045081_CR89","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/S0022-3476(05)80913-8","volume":"120","author":"A. Tolaymat","year":"1992","unstructured":"Tolaymat, A., B. Leventhal, A. Sakarcan, H. Kashima, C. Monteiro: Systemic lupus erythematosus in a child receiving long-term interferon therapy. J. Pediat. 120 (1992), 429\u2013432.","journal-title":"J. Pediat."},{"key":"BF03045081_CR90","first-page":"722","volume":"16","author":"A. Tran","year":"1992","unstructured":"Tran, A., C. Beusnel, M.-L. Montoya, V. Lussiez, X. H\u00e9buterne, P. Rampal: H\u00e9patite auto-immune de type 1 r\u00e9v\u00e9l\u00e9e par un traitement par interf\u00e9ron. Gastroent. clin. Biol. 16 (1992), 722\u2013723.","journal-title":"Gastroent. clin. Biol."},{"key":"BF03045081_CR91","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1002\/hep.1840180205","volume":"18","author":"A. Tran","year":"1993","unstructured":"Tran, A., J.-F. Quaranta, S. Benzaken, V. Thiers, H. T. Chau, P. Hastier, D. Regnier, G. Dreyfus, C. Pradier, J.-L. Sadoul, X. H\u00e9buterne, P. Rampal: High prevalence of thyroid autoantibodies in a prospective series of patients with chronic hepatitis C before interferon therapy. Hepatology 18 (1993), 253\u2013257.","journal-title":"Hepatology"},{"key":"BF03045081_CR92","first-page":"1165","volume":"38","author":"H. Ueda","year":"1992","unstructured":"Ueda, H., A. Ishikawa, S. Itoh, M. Kusaka, H. Azuma, T. Suzuki, N. Takasaki, K. Isurugi, N. Ueno, A. Demura: Hypothyroidism followed by interferon-alpha as adjuvant therapy of renal cell carcinoma: a case report (Zusammenfassung). Hinyokika-Kiyo 38 (1992), 1165\u20131169.","journal-title":"Hinyokika-Kiyo"},{"key":"BF03045081_CR93","first-page":"391","volume":"20","author":"K. Ueki","year":"1989","unstructured":"Ueki, K., A. Tsuchida, H. Murakami, S. Yano, N. Kobayashi, M. Omine, T. Naruse: Hypoparathyroidism during \u03b1-interferon therapy in a patient with multiple myeloma. J. Med. 20 (1989), 391\u2013397.","journal-title":"J. Med."},{"key":"BF03045081_CR94","doi-asserted-by":"crossref","first-page":"266","DOI":"10.7326\/0003-4819-117-3-266_2","volume":"117","author":"Y. Ueno","year":"1992","unstructured":"Ueno, Y., T. Sohma: Alpha-interferon-induced nodular rheumatoid arthritis in renal cell carcinoma. Ann. intern. Med. 117 (1992), 266\u2013267.","journal-title":"Ann. intern. Med."},{"key":"BF03045081_CR95","first-page":"224","volume":"1","author":"P. A. Liesum Van","year":"1989","unstructured":"Van Liesum, P. A., P. H. M. De Mulder, E. J. M. Mattijssen, F. H. M. Corstens, D. J. T. Wagener: Hypothyroidism and goitre during interleukin-2 therapy without LAK cells. Lancet 1 (1989), 224.","journal-title":"Lancet"},{"key":"BF03045081_CR96","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1016\/S0140-6736(89)91595-X","volume":"2","author":"S. Vento","year":"1989","unstructured":"Vento, S., G. Di Perri, T. Garofano, L. Cosco, E. Concia, T. Ferraro, D. Bassetti: Hazards of interferon therapy for HBV-seronegative chronic hepatitis. Lancet 2 (1989), 926.","journal-title":"Lancet"},{"key":"BF03045081_CR97","doi-asserted-by":"crossref","first-page":"115","DOI":"10.2165\/00002018-199410020-00003","volume":"10","author":"T. Vial","year":"1994","unstructured":"Vial, T., J. Descotes: Clinical toxicity of the interferons. Drug Saf. 10 (1994) 115\u2013150.","journal-title":"Drug Saf."},{"key":"BF03045081_CR98","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/0168-8227(94)90124-4","volume":"23","author":"M. Waguri","year":"1994","unstructured":"Waguri, M., T. Hanafusa, N. Itoh, A. Imagawa, J. Miyagawa, S. Kawata, N. Kono, M. Kuwajima, Y. Matsuzawa: Occurence of IDDM during interferon therapy for chronic viral hepatitis. Diabetes Res. clin. Pract. 23 (1994), 33\u201336.","journal-title":"Diabetes Res. clin. Pract."},{"key":"BF03045081_CR99","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/0090-1229(92)90250-R","volume":"65","author":"U. B. Wandl","year":"1992","unstructured":"Wandl, U. B., M. Nagel-Hiemke, D. May, E. Kreuzfelder, O. Kloke, M. Kranzhoff, S. Seeber, N. Niederle: Lupus-like autoimmune disease induced by interferon therapy for myeloproliferative disorders. Clin. Immunol. Immunopath. 65 (1992), 70\u201374.","journal-title":"Clin. Immunol. Immunopath."},{"key":"BF03045081_CR100","first-page":"399","volume":"89","author":"U. Watanabe","year":"1994","unstructured":"Watanabe, U., E. Hashimoto, T. Hisamitsu, H. Obata, N. Hayashi: The risk factor for development of thyroid disease during interferon-\u03b1 therapy for chronic hepatitis C Amer. J. Gastroent. 89 (1994), 399\u2013403.","journal-title":"Amer. J. Gastroent."},{"key":"BF03045081_CR101","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/S0168-8278(94)80002-2","volume":"20","author":"P. Weber","year":"1994","unstructured":"Weber, P., K. H. Wiedermann, R. Klein, E. Walter, H. E. Blum, P. A. Berg: Induction of autoimmune phenomena in patients with chronic hepatitis B infection treated with gamma-interferon. J. Hepatol. 20 (1994), 321\u2013328.","journal-title":"J. Hepatol."},{"issue":"Suppl. 5","key":"BF03045081_CR102","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/BF02989219","volume":"28","author":"M. Yoshikawa","year":"1993","unstructured":"Yoshikawa, M., T. Sakamoto, A. Mitoro, T. Mochi, H. Tsujii, M. Koizumi, H. Yoshiji, Y. Yakaguchi, H. Fukui, H. Nakano et al.: Autoimmunity during alpha-interferon therapy for chronic hepatitis C (Zusammenfassung). Gastroent. Jap. 28, Suppl. 5 (1993), 109\u2013114.","journal-title":"Gastroent. Jap."}],"container-title":["Medizinische Klinik"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF03045081.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF03045081\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF03045081","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,25]],"date-time":"2023-05-25T16:59:06Z","timestamp":1685033946000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF03045081"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1997,5]]},"references-count":102,"journal-issue":{"issue":"5","published-print":{"date-parts":[[1997,5]]}},"alternative-id":["BF03045081"],"URL":"https:\/\/doi.org\/10.1007\/bf03045081","relation":{},"ISSN":["0723-5003","1615-6722"],"issn-type":[{"value":"0723-5003","type":"print"},{"value":"1615-6722","type":"electronic"}],"subject":[],"published":{"date-parts":[[1997,5]]}}}